{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:58:47Z","timestamp":1790355527032,"version":"4.1.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2008,7,31]],"date-time":"2008-07-31T00:00:00Z","timestamp":1217462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pathogenic causes underlying nonischemic cardiomyopathies are increasingly being resolved, yet repair therapies for these commonly heritable forms of heart failure are lacking. A case in point is human dilated cardiomyopathy 10 (CMD10; Online Mendelian Inheritance in Man #608569), a progressive organ dysfunction syndrome refractory to conventional therapies and linked to mutations in cardiac ATP-sensitive K+ (KATP) channel subunits. Embryonic stem cell therapy demonstrates benefit in ischemic heart disease, but the reparative capacity of this allogeneic regenerative cell source has not been tested in inherited cardiomyopathy. Here, in a Kir6.2-knockout model lacking functional KATP channels, we recapitulated under the imposed stress of pressure overload the gene-environment substrate of CMD10. Salient features of the human malignant heart failure phenotype were reproduced, including compromised contractility, ventricular dilatation, and poor survival. Embryonic stem cells were delivered through the epicardial route into the left ventricular wall of cardiomyopathic stressed Kir6.2-null mutants. At 1 month of therapy, transplantation of 200,000 cells per heart achieved teratoma-free reversal of systolic dysfunction and electrical synchronization and halted maladaptive remodeling, thereby preventing end-stage organ failure. Tracked using the lacZ reporter transgene, stem cells engrafted into host heart. Beyond formation of cardiac tissue positive for Kir6.2, transplantation induced cell cycle activation and halved fibrotic zones, normalizing sarcomeric and gap junction organization within remuscularized hearts. Improved systemic function induced by stem cell therapy translated into increased stamina, absence of anasarca, and benefit to overall survivorship. Embryonic stem cells thus achieve functional repair in nonischemic genetic cardiomyopathy, expanding indications to the therapy of heritable heart failure.<\/jats:p>\n               <jats:p>Disclosure of potential conflicts of interest is found at the end of this article.<\/jats:p>","DOI":"10.1634\/stemcells.2008-0187","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T02:18:48Z","timestamp":1217557128000},"page":"2644-2653","source":"Crossref","is-referenced-by-count":66,"title":["Embryonic Stem Cell Therapy of Heart Failure in Genetic Cardiomyopathy"],"prefix":"10.1093","volume":"26","author":[{"given":"Satsuki","family":"Yamada","sequence":"first","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben J.","family":"Crespo-Diaz","sequence":"additional","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Perez-Terzic","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ke","family":"Liu","sequence":"additional","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Autonomic Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Seino","sequence":"additional","affiliation":[{"name":"Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta","family":"Behfar","sequence":"additional","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Terzic","sequence":"additional","affiliation":[{"name":"Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,31]]},"reference":[{"key":"2022011315212137900_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/415227a","article-title":"The failing heart","volume":"415","author":"Towbin","year":"2002","journal-title":"Nature"},{"key":"2022011315212137900_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.genom.6.080604.162132","article-title":"The genetic basis for cardiac remodeling","volume":"6","author":"Ahmad","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2022011315212137900_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80043-4","article-title":"Stress pathways and heart failure","volume":"98","author":"Chien","year":"1999","journal-title":"Cell"},{"key":"2022011315212137900_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2006.10.073","article-title":"Cardiomyopathies: Therapeutics based on molecular phenotype","volume":"49","author":"Ashrafian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022011315212137900_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1329","article-title":"ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating","volume":"36","author":"Bienengraeber","year":"2004","journal-title":"Nat Genet"},{"key":"2022011315212137900_bib6","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/hmg\/ddl154","article-title":"KCNJ11 gene knockout of the Kir62 KATP channel causes maladaptive remodeling and heart failure in hypertension","volume":"15","author":"Kane","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2022011315212137900_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1113\/jphysiol.2006.119511","article-title":"Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant","volume":"577","author":"Yamada","year":"2006","journal-title":"J Physiol"},{"key":"2022011315212137900_bib8","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1073\/pnas.212315199","article-title":"Kir6.2 is required for adaptation to stress","volume":"99","author":"Zingman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022011315212137900_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.mp.4001323","article-title":"Stress without distress: Homeostatic role for KATP channels","volume":"8","author":"Zingman","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"suppl 3","key":"2022011315212137900_bib10","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.2337\/diabetes.53.suppl_3.S169","article-title":"ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits","volume":"53","author":"Kane","year":"2004","journal-title":"Diabetes"},{"key":"2022011315212137900_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.yjmcc.2005.02.026","article-title":"Cardiac KATP channels in health and disease","volume":"38","author":"Kane","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2022011315212137900_bib12","doi-asserted-by":"crossref","first-page":"H543","DOI":"10.1152\/ajpheart.00051.2006","article-title":"Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits","volume":"291","author":"Tong","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022011315212137900_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1172\/JCI200524283","article-title":"Unchain my heart: The scientific foundations of cardiac repair","volume":"115","author":"Dimmeler","year":"2005","journal-title":"J Clin Invest"},{"key":"2022011315212137900_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nature04961","article-title":"Potential of stem-cell-based therapies for heart disease","volume":"441","author":"Srivastava","year":"2006","journal-title":"Nature"},{"key":"2022011315212137900_bib15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2022011315212137900_bib16","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1038\/ncpcardio0456","article-title":"Contemplating the bright future of stem cell therapy for cardiovascular disease","volume":"3","author":"S\u00e1nchez","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"suppl 1","key":"2022011315212137900_bib17","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1038\/ncpcardio0744","article-title":"Bone-marrow-derived cells for cardiac stem cell therapy: Safe or still under scrutiny?","volume":"4","author":"Bartunek","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.CIR.0000142861.55862.15","article-title":"Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?","volume":"110","author":"Pouly","year":"2004","journal-title":"Circulation"},{"key":"2022011315212137900_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/07853890500327843","article-title":"Cardiomyocytes derived from stem cells","volume":"37","author":"Van Laake","year":"2005","journal-title":"Ann Med"},{"key":"2022011315212137900_bib20","first-page":"293","article-title":"The potential of embryonic stem cells to treat heart disease","volume":"7","author":"Menasch\u00e9","year":"2005","journal-title":"Curr Opin Mol Ther"},{"key":"2022011315212137900_bib21","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1084\/jem.20061469","article-title":"Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium","volume":"203","author":"Kolossov","year":"2006","journal-title":"J Exp Med"},{"key":"2022011315212137900_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrg1827","article-title":"From teratocarcinomas to embryonic stem cells and beyond: A history of embryonic stem cell research","volume":"7","author":"Solter","year":"2006","journal-title":"Nat Rev Genet"},{"key":"2022011315212137900_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000080317.92718.99","article-title":"Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization","volume":"93","author":"He","year":"2003","journal-title":"Circ Res"},{"issue":"suppl 1","key":"2022011315212137900_bib24","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/ncpcardio0766","article-title":"Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells","volume":"4","author":"Chung","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"suppl 1","key":"2022011315212137900_bib25","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1038\/ncpcardio0763","article-title":"Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery.","volume":"4","author":"Perez-Terzic","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib26","doi-asserted-by":"crossref","first-page":"H471","DOI":"10.1152\/ajpheart.01247.2003","article-title":"Stable benefit of embryonic stem cell therapy in myocardial infarction","volume":"287","author":"Hodgson","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022011315212137900_bib27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(05)67380-1","article-title":"Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study","volume":"366","author":"M\u00e9nard","year":"2005","journal-title":"Lancet"},{"key":"2022011315212137900_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1334.018","article-title":"Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair","volume":"1049","author":"Behfar","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"2022011315212137900_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ar.a.20388","article-title":"Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells","volume":"288","author":"Nelson","year":"2006","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"2022011315212137900_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yjmcc.2005.09.001","article-title":"Transplantation of embryonic stem cells into the infarcted mouse heart: Formation of multiple cell types","volume":"40","author":"Singla","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2022011315212137900_bib31","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1096\/fj.02-0072com","article-title":"Stem cell differentiation requires a paracrine pathway in the heart","volume":"16","author":"Behfar","year":"2002","journal-title":"FASEB J"},{"key":"2022011315212137900_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.20061916","article-title":"Cardiopoietic programming of embryonic stem cells for tumor-free heart repair","volume":"204","author":"Behfar","year":"2007","journal-title":"J Exp Med"},{"key":"2022011315212137900_bib33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1113\/jphysiol.2006.115816","article-title":"Heart repair and stem cells","volume":"577","author":"van Laake","year":"2006","journal-title":"J Physiol"},{"issue":"suppl 1","key":"2022011315212137900_bib34","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/ncpcardio0402","article-title":"Embryonic stem cells prevent developmental cardiac defects in mice.","volume":"3","author":"Fraidenraich","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib35","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1073\/pnas.95.18.10402","article-title":"Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice","volume":"95","author":"Miki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 3","key":"2022011315212137900_bib36","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/diabetes.53.suppl_3.S165","article-title":"Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia","volume":"53","author":"Liu","year":"2004","journal-title":"Diabetes"},{"key":"2022011315212137900_bib37","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1096\/fj.06-6349com","article-title":"Gene knockout of the KCNJ8-encoded Kir6.1 KATP channel imparts fatal susceptibility to endotoxemia","volume":"20","author":"Kane","year":"2006","journal-title":"FASEB J"},{"key":"2022011315212137900_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/35025196","article-title":"Genomic circuits and the integrative biology of cardiac diseases","volume":"407","author":"Chien","year":"2000","journal-title":"Nature"},{"key":"2022011315212137900_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodeling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"key":"2022011315212137900_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature02624","article-title":"Predicting disease using genomics","volume":"429","author":"Bell","year":"2004","journal-title":"Nature"},{"issue":"suppl 1","key":"2022011315212137900_bib41","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1038\/ncpcardio0400","article-title":"Cardiac cell-repair therapy: Clinical issues","volume":"3","author":"Gersh","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/415240a","article-title":"Myocyte renewal and ventricular remodelling","volume":"415","author":"Anversa","year":"2002","journal-title":"Nature"},{"key":"2022011315212137900_bib43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/physrev.00013.2005","article-title":"Cardiac stem cells and mechanisms of myocardial regeneration","volume":"85","author":"Leri","year":"2005","journal-title":"Physiol Rev"},{"issue":"suppl 1","key":"2022011315212137900_bib44","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/ncpcardio0771","article-title":"The adult human heart as a source for stem cells: Repair strategies with embryonic-like progenitor cells","volume":"4","author":"Ott","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"suppl 1","key":"2022011315212137900_bib45","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1038\/ncpcardio0773","article-title":"Myocyte death and renewal: Modern concepts of cardiac cellular homeostasis","volume":"4","author":"Ellison","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib46","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.jacc.2007.01.095","article-title":"Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure","volume":"49","author":"Kissel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022011315212137900_bib47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","article-title":"Aging and disease as modifiers of efficacy of cell therapy","volume":"102","author":"Dimmeler","year":"2008","journal-title":"Circ Res"},{"key":"2022011315212137900_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/01.RES.0000059415.25070.54","article-title":"Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes","volume":"92","author":"Perez-Terzic","year":"2003","journal-title":"Circ Res"},{"key":"2022011315212137900_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature07040","article-title":"Stem-cell-based therapy and lessons from the heart","volume":"453","author":"Passier","year":"2008","journal-title":"Nature"},{"key":"2022011315212137900_bib50","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nbt1014","article-title":"Electromechanical integration of cardiomyocytes derived from human embryonic stem cells","volume":"10","author":"Kehat","year":"2004","journal-title":"Nat Biotechnol"},{"key":"2022011315212137900_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cell.2008.02.008","article-title":"Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development","volume":"132","author":"Murry","year":"2008","journal-title":"Cell"},{"key":"2022011315212137900_bib52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.WCB.0000071886.63724.FB","article-title":"Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke","volume":"23","author":"Erd\u00f6","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"2022011315212137900_bib53","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.142298299","article-title":"Characterization of the expression of MHC proteins in human embryonic stem cells","volume":"99","author":"Drukker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022011315212137900_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0202-171","article-title":"Preimplantation-stage stem cells induce long-term allogenic graft acceptance without supplementary host conditioning","volume":"8","author":"F\u00e4ndrich","year":"2002","journal-title":"Nat Med"},{"key":"2022011315212137900_bib55","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation"},{"key":"2022011315212137900_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1634\/stemcells.2007-0151","article-title":"Immunosuppression by embryonic stem cells","volume":"26","author":"Koch","year":"2008","journal-title":"Stem Cells"},{"key":"2022011315212137900_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ncpcardio0792","article-title":"KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation","volume":"4","author":"Olson","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022011315212137900_bib58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-008-0519-3","article-title":"KATP channel polymorphism is associated with left ventricular size in hypertensive individuals: A large-scale community-based study","volume":"123","author":"Reyes","year":"2008","journal-title":"Hum Genet"},{"key":"2022011315212137900_bib59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.clpt.6100310","article-title":"Pharmacoproteomics: Advancing the efficacy and safety of regenerative therapeutics","volume":"82","author":"Arrell","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"2022011315212137900_bib60","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1152\/japplphysiol.00713.2007","article-title":"Cardioprotective repair through stem cell-based cardiopoiesis","volume":"103","author":"Behfar","year":"2007","journal-title":"J Appl Physiol"},{"key":"2022011315212137900_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1634\/stemcells.2007-0599","article-title":"Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of TNF\u03b1-primed endodermal secretome","volume":"26","author":"Arrell","year":"2008","journal-title":"Stem Cells"},{"key":"2022011315212137900_bib62","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/gb-2008-9-1-r6","article-title":"Genomic chart guiding embryonic stem cell cardiopoiesis","volume":"9","year":"2008","journal-title":"Genome Biol"},{"key":"2022011315212137900_bib63","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1634\/stemcells.2007-0808","article-title":"CXCR4+\/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells","volume":"26","author":"Nelson","year":"2008","journal-title":"Stem Cells"},{"key":"2022011315212137900_bib64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature07037","article-title":"Regenerative medicine and human models of human disease","volume":"452","author":"Chien","year":"2008","journal-title":"Nature"},{"key":"2022011315212137900_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.clpt.6100398","article-title":"Individualized medicine and the imperative of global health","volume":"82","author":"Waldman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"2022011315212137900_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/clpt.2008.65","article-title":"Therapeutic targeting: A crucible for individualized medicine","volume":"83","author":"Waldman","year":"2008","journal-title":"Clin Pharmacol Ther"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1634%2Fstemcells.2008-0187","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/stemcells.2008-0187","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/stemcells.2008-0187","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/26\/10\/2644\/41945555\/stmcls_26_10_2644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/26\/10\/2644\/41945555\/stmcls_26_10_2644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:55:52Z","timestamp":1642560952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/26\/10\/2644-2653\/6403095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,31]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2008,7,31]]},"published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1634\/stemcells.2008-0187","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,10,1]]},"published":{"date-parts":[[2008,7,31]]}}}